Equities

Nagaileben Co Ltd

Nagaileben Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,260.00
  • Today's Change36.00 / 1.62%
  • Shares traded17.50k
  • 1 Year change+1.80%
  • Beta0.2703
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Aug 31 2024202420232022
ASSETS
Cash And Short Term Investments26,34927,15928,561
Total Receivables, Net5,0054,9815,243
Total Inventory6,5916,0604,886
Prepaid expenses------
Other current assets, total340795213
Total current assets38,28638,99538,902
Property, plant & equipment, net7,3137,3127,382
Goodwill, net------
Intangibles, net736057
Long term investments194183174
Note receivable - long term----1.85
Other long term assets186191177
Total assets46,72747,37847,348
LIABILITIES
Accounts payable1,2981,6061,608
Accrued expenses868589
Notes payable/short-term debt--00
Current portion long-term debt/capital leases------
Other current liabilities, total1,7231,5322,352
Total current liabilities3,1063,2244,049
Total long term debt--00
Total debt--00
Deferred income tax------
Minority interest------
Other liabilities, total9249401,044
Total liabilities4,0304,1645,093
SHAREHOLDERS EQUITY
Common stock1,9251,9251,925
Additional paid-in capital1,9381,9301,923
Retained earnings (accumulated deficit)44,71943,82342,533
Treasury stock - common(5953)(4514)(4151)
Unrealized gain (loss)787267
Other equity, total(9.53)(23)(42)
Total equity42,69743,21442,255
Total liabilities & shareholders' equity46,72747,37847,348
Total common shares outstanding313232
Treasury shares - common primary issue4.253.633.48
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.